Spain· ES:90019
PROVINGO 40 MG/5 ML SOLUCION INYECTABLE
A medicinal product containing carmín de índigo, registered in Spain by Provepharm.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- carmín de índigo
- Manufacturer
- Provepharm
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- June 3, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Carmín de índigo in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumCarmin d’Indigo Serb 40 mg/5 mlSERB
- United KingdomBlumyne 40mg/5ml solution for injection ampoulesProvepharm UK Ltd
- United StatesBludigoSagent Pharmaceuticals
- GermanyIndigocarmin ProvingoProvepharm Sas
- NetherlandsIndigokarmijn Provingo 40 mg/5 ml, oplossing voor injectieProvepharm SAS
- FinlandCarmyneSERB S.A.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1d0cfb84-045d-4b89-9d39-c728879dd012 GET /v1/drugs/1d0cfb84-045d-4b89-9d39-c728879dd012?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Uso Hospitalario",
"estado": "{\"aut\":1763553843000}",
"nregistro": "90019",
"substance": "carmín de índigo"
}See everything about carmín de índigo.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.